RAS Mutation

Explore clinical trials studying RAS Mutation. Study availability and eligibility vary by location and protocol.

13 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

RAS Mutation trial results

Recruiting

NCT07746141

Conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +5 more
Locations: Icon Cancer Centre South Brisbane South Brisbane, Queensland, Australia

Cabrini Hospital Malvern Malvern, Victoria, Australia

Recruiting

NCT06321081

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
Locations: Beijing Hospital Beijing, Beijing Municipality, China

Recruiting

NCT04678648

Conditions: Advanced Malignant Solid Neoplasm, Astrocytoma, Colon Cancer, +35 more
Locations: University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology Los Angeles, California, United States

Sarah Cannon, SCRI Oncology Partners - Health One Denver, Colorado, United States

Sarah Cannon, SCRI Oncology Partners Nashville, Tennessee, United States

Recruiting

NCT07252479

Conditions: RAS Mutation, Solid Tumors (Phase 1)
Locations: Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States

H. Lee Moffit Cancer Center and Research Institute Hospital, Inc. Tampa, Florida, United States

University of Texas MD Anderson Cancer Center Houston, Texas, United States

Recruiting

NCT06922591

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +12 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Sarah Cannon Research Institute Denver Denver, Colorado, United States

Georgetown University Medical Center Washington D.C., District of Columbia, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

View all 18 locations

Recruiting

NCT04395495

Conditions: Abnormalities, Multiple, Cardiofaciocutaneous Syndrome, Cardiofaciocutaneous syndrome, +48 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Recruiting

NCT06299839

Conditions: Advanced Solid Tumors, NF1 Mutation, Neoplasms, +2 more
Locations: NEXT Oncology Austin, Texas, United States

NEXT Oncology Irving, Texas, United States

NEXT Oncology San Antonio, Texas, United States

NEXT Oncology Fairfax, Virginia, United States

Recruiting

NCT06229340

Conditions: Colonic Diseases, Colorectal Cancer Recurrent, Colorectal Neoplasms, +33 more
Locations: Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation Saint Petersburg, Russia